Lead sponsor

Mount Sinai Hospital, Canada

4 GLP-1 and incretin trials led. Source: ClinicalTrials.gov, as of July 1, 2026.

4

Trials led

1

Active

288

Total enrollment

1

Sites

Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.

Portfolio

How this sponsor's trials break down

Trials by phase

Phase 3
3
Phase 4
1

Trials by status

Recruiting
1
Completed
3

Trials led

PREVAILBMI ≥23Ph 3Completed105
RESTBMI ≥30Ph 3Recruiting98
LIBRAHbA1c 5.5-9%Ph 3Completed63
BOLTHbA1c 6.5-10%Ph 4Completed22